Edgewise Therapeutics Inc...

NASDAQ: EWTX · Real-Time Price · USD
14.15
0.22 (1.58%)
At close: Aug 15, 2025, 3:59 PM
14.31
1.10%
After-hours: Aug 15, 2025, 05:00 PM EDT

Edgewise Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-36.12M -40.8M -39.66M -34.13M -31.5M -28.52M -30.14M -25.71M -21.47M -22.84M -19.41M -17.5M -16.07M -14.66M -12.7M -12.95M -10.35M -6.82M
Depreciation & Amortization
567K 554K 629K 602K 534K 525K 533K 497K 461K 241K 92K 165K 154K 127K 78K 64K 51K 79K
Stock-Based Compensation
7.73M 9.06M 7.74M 6.88M 5.22M 4.87M 5.15M 4.56M 4.01M 3.84M 3.74M 3.17M 2.04M 1.98M 1.87M 1.55M 687K 296K
Other Working Capital
-2.41M -7.62M 6.85M 3.54M 1.3M -3.1M 1.18M -788K -30K -1.83M 4.95M 1.1M -129K -1.88M -225K 3.6M -1.84M 446K
Other Non-Cash Items
-2.2M -1.92M -2.6M -3.24M -3.55M -3.15M 1.13M -4.56M -4.01M -2.08M -1.75M 127K 415K 670K 4.63M 2.2M -901K 517K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.3M 2.18M 1.12M n/a n/a n/a n/a n/a -4.63M n/a n/a n/a
Change in Working Capital
-2.56M -4.76M 6.94M 2.51M 3.19M -2.32M -201K 974K -342K -1.99M 5.52M 2.04M -2.78M -687K 1.33M 3.08M -154K 383K
Operating Cash Flow
-32.58M -37.87M -26.96M -27.37M -26.1M -28.6M -26.83M -22.06M -20.23M -22.83M -11.82M -12M -16.25M -12.57M -9.42M -8.26M -9.77M -6.06M
Capital Expenditures
-50K -44K -274K -520K -221K -297K -161K -457K -759K -4.37M -3.29M -1.33M -554K -369K -79K -451K -76K -62K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -27.14K -23.88K -4.2K -53.41K 72.3K 24.99K -508 n/a 7.2M n/a n/a n/a
Purchase of Investments
-263.76M -122.18M -63.18M -45.32M -40.95M -327.6M -39.79M -84.67M -114.45M -16.96M -146.69M -67.99M -63.75M -13.96M -15.04M -41.36M -167.09M -64.71M
Sales Maturities Of Investments
101.65M 166.12M 84.37M 71.2M 78.54M 59.59M 66.93M 108.54M 118.66M 70.37M 74.39M 43M 64.26M 45.71M 29.24M 10.2M 7.2M n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 27.14K 23.88K 4.2K 53.41K -72.3K -24.99K 508.00 31.75M -7.2M -31.16M 7.2M -64.71M
Investing Cash Flow
-162.17M 43.9M 20.92M 25.36M 37.37M -268.31M 26.98M 23.42M 3.44M 49.04M -75.6M -26.32M -46K 31.39M 14.12M -31.61M -159.97M -64.77M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -35K 35K n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
598K n/a 242.04M 48K -48K 1.93M 369K n/a 369K 21K 85K -35K 179K 73K 293K 37K n/a -101K
Financial Cash Flow
188.23M 2.22M 2.9M 3.33M 1.95M 241.07M 52.99M -211K 369K 21K -338K 129.72M 179K 73K 293K 37K -896K 186.95M
Net Cash Flow
-6.52M 8.26M -3.14M 1.32M 13.22M -55.83M 53.14M 1.15M -16.42M 26.24M -87.75M 91.41M -16.11M 18.89M 5M -39.83M -170.63M 116.12M
Free Cash Flow
-32.63M -37.91M -27.23M -27.89M -26.32M -28.89M -26.99M -22.52M -20.99M -27.19M -15.11M -13.33M -16.8M -12.94M -9.5M -8.71M -9.85M -6.12M